B16172 variant: The UK needs to brace for more cases, despite vaccine effectiveness
Incentives to boost vaccine uptake in Australia need multiple approaches
26 May 2021Many with inoperable pancreatic cancer are not prescribed cheap-but-essential medication
26 May 2021B16172 variant: The UK needs to brace for more cases, despite vaccine effectiveness
The B16172 variant is now dominant in the UK, and there have been fears that its sudden rise could derail Britain’s exit from lockdown. Scientists—including me—have predicted previously that B16172 and other closely related variants could, because of the mutations they carry, be resistant to vaccines.
